Analysis
OpenEvidence, the innovative company building "ChatGPT for doctors," has secured a massive $12 billion valuation in its latest funding round. This rapid growth, significantly up from its October valuation, signals tremendous investor confidence in the future of AI-powered healthcare and its potential to revolutionize the medical field!
Key Takeaways
- •OpenEvidence, the company behind "ChatGPT for doctors," raised $250 million in a new funding round.
- •The company's valuation has skyrocketed to $12 billion, demonstrating significant growth since October.
- •The funding round was led by Thrive and DST, highlighting investor confidence in AI's medical applications.
Reference / Citation
View Original"OpenEvidence, which is building “ChatGPT for doctors”, raised $250M led by Thrive and DST at a $12B valuation, up from $6B in October and $1B in February 2025"